Risk factors and outcome associated with infection or colonization due to carbapenem-heteroresistant Escherichia coli.
Karen K TanCorey KelsomAmanda ChronPaul NiebergHolly HuseAnnie Wong-BeringerPublished in: JAC-antimicrobial resistance (2021)
Our findings deserve confirmation with a larger study population and call attention to the potential for increased morbidity with cHR ESBL-EC infections, which underscores the need to screen for cHR phenotype in patients with repeated growth of ESBL-EC, particularly from systemic sites and patients that have had extensive carbapenem exposure.
Keyphrases
- klebsiella pneumoniae
- escherichia coli
- risk factors
- end stage renal disease
- multidrug resistant
- acinetobacter baumannii
- ejection fraction
- newly diagnosed
- gram negative
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- working memory
- drug resistant
- risk assessment
- cystic fibrosis
- climate change
- biofilm formation
- single cell